[DOI] [PubMed] [Google Scholar] 97.Meijnikman A S, Nieuwdorp M, Schnabl B
When you feel strong, hydrated, and protected, you have more to give back to your community and the causes you care about
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.03 - HYPERACUTE MANAGEMENT P667 - ESOC25-2238 DIAGNOSTIC ACCURACY OF POINT-OF-CARE VISCOELASTIC ASSESSMENT OF DIRECT ORAL ANTICOAGULATION IN ACUTE ISCHEMIC STROKE: INTERIM RESULTS FROM A PROSPECTIVE VALIDATION STUDY Annahita Sedghi 1 , Eva Meyer-Bender 1 , Lars Heubner 2 , Joerg Pietsch 3 , Oliver Tiebel 4 , Kristian Barlinn 1 , Jan Beyer-Westendorf 5 , Volker Puetz 1 , Peter Spieth 2 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 2 Department of Anesthesiology and Intensive Care Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 3 Institute of Legal Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 4 Institute of Clinical Chemistry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 5 Thrombosis Research Unit, Department of Medicine I, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: Intravenous thrombolysis in patients with acute ischemic stroke (AIS) is often delayed because of uncertainty about the presence of direct oral anticoagulants (DOACs)
Khc vi L-Glutathione thng thng, Setria L-glutathione c tinh khit trn 99%, p ng chun Dc in Nht Bn JP (Japanese Pharmacopoeia) v chun Dc in Hoa K USP (United States Pharmacopeia)
